Company / Total Assets
Bioventus Inc. Total Assets History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$683.6M
FY2025
5-year range
$683.6M / $1.4B
FY2021-FY2025
Trend
-6.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has declined for 3 consecutive years, from $1.4B in FY2022 to $684M in FY2025.
Based on SEC 10-K filings.
$684M in FY2025 with a 3-year CAGR of -20.7%.
Declined from $811M to $684M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -20.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Bioventus Inc.'s total assets has declined for 3 consecutive years.
- 3-year CAGR of -20.7%, indicating a declining trend.
- In FY2025, total assets decreased 6.1% year-over-year.
- Peak total assets was recorded in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $683.6M | -6.1% |
| FY2024 | $728.0M | -10.2% |
| FY2023 | $810.9M | -40.9% |
| FY2022 | $1.4B | +12.0% |
| FY2021 | $1.2B | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026